OTCMKTS:GNWSF StageZero Life Sciences (GNWSF) Stock Price, News & Analysis $0.02 0.00 (0.00%) As of 07/7/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartHeadlinesSEC FilingsBuy This Stock About StageZero Life Sciences Stock (OTCMKTS:GNWSF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get GNWSF alerts:Sign Up Key Stats Today's Range$0.02▼$0.0250-Day Range$0.00▼$0.0352-Week Range$0.00▼$1.27VolumeN/AAverage Volume26,719 shsMarket Capitalization$1.44 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview StageZero Life Sciences Ltd. develops and commercializes proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology is Sentinel Principle, which identifies novel biomarkers from whole blood. The company's lead product is ColonSentry, a blood test to determine an individual's current risk for having colorectal cancer. It also offers Aristotle, a multi-cancer panel test for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer; and COVID PCR testing and blood test analysis. StageZero Life Sciences Ltd. is headquartered in Richmond Hill, Canada. Read More Receive GNWSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address GNWSF Stock News HeadlinesStageZero Announces Partial Revocation of Cease Trade Order and Proposed FinancingMay 9, 2025 | stockhouse.comWave Life Sciences: Promising Growth with Strategic Innovations and Market ExpansionOctober 31, 2024 | markets.businessinsider.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. July 8 at 2:00 AM | Altimetry (Ad)5 things to know about the Texas Research Quarter, the life sciences hub planned for PlanoOctober 15, 2024 | msn.comChicago Beat: Looking at local life-sciences growth, Crafty gets new fundingOctober 11, 2024 | bizjournals.comNew Hampshire Life Sciences hosts Inaugural Live Free Life Science EventOctober 10, 2024 | yahoo.comHow Boy Meets World’s Ben Savage Views Maitland Ward's Porn CareerSeptember 25, 2024 | msn.comChicago Beat: NanoGraf expands footprint, what's next for life sciences in ChicagoSeptember 25, 2024 | bizjournals.comSee More Headlines GNWSF Stock Analysis - Frequently Asked Questions How have GNWSF shares performed this year? StageZero Life Sciences' stock was trading at $0.0016 at the beginning of the year. Since then, GNWSF shares have increased by 1,325.0% and is now trading at $0.0228. How do I buy shares of StageZero Life Sciences? Shares of GNWSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostic Substances Sub-IndustryN/A Current SymbolOTCMKTS:GNWSF CIK1454263 Webwww.stagezerolifesciences.com Phone905-209-2030FaxN/AEmployees80Year FoundedN/AProfitability EPS (Trailing Twelve Months)($0.28) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.86 million Net Margins-200.26% Pretax MarginN/A Return on EquityN/A Return on Assets-165.13% Debt Debt-to-Equity RatioN/A Current Ratio1.15 Quick Ratio1.08 Sales & Book Value Annual Sales$4.15 million Price / Sales0.35 Cash FlowN/A Price / Cash FlowN/A Book Value($0.02) per share Price / Book-1.14Miscellaneous Outstanding Shares62,995,000Free FloatN/AMarket Cap$1.44 million OptionableNot Optionable Beta0.28 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (OTCMKTS:GNWSF) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | Sponsored$3,200 from your phone?No charts. No crypto. No stock picking. With just a regular brokerage app and Jeff Clark’s “Crossfire” meth...TradeSmith | SponsoredElon brings 'disruption and chaos ' to DCWhat it's really like to work with Elon... "A business partner of mine has close ties to the Department of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
